Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Squarticles effectively deliver hair growth drugs to follicles and dermal papilla cells.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

HIV can cause unusual and severe skin problems that are hard to treat.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

New alopecia treatments aim for better results and fewer side effects.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Personalized treatment plans are important for people with alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

A patient with complete hair loss regrew all her hair using tofacitinib.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.